Explorez tous les épisodes du podcast From Lab to Launch by Qualio
| Titre | Date | Durée | |
|---|---|---|---|
| Labor of love with Laurie & John Masiello, co-founders of Predictive Monitor | 10 Nov 2025 | 00:25:52 | |
Today, we're thrilled to talk to husband-and-wife dream team, Laurie & John Masiello. The Masiellos have been launching and scaling life science companies together since 1984. After merging their first company, Masy BioServices, with a North Carolina CDMO in 2021, the Masiellos struck again, forming Predictive Monitor in 2022. Their debut product, OverShield, combines IoT sensor technology with AI and data analysis to offer a powerful early warning system for controlled GMP chambers, from freezers to cold and stability rooms. The couple’s mission centers around harnessing Pharma 4.0 technology to maximize equipment uptime, improve operational efficiency, and protect life-saving biopharmaceutical products. Hear Laurie & John walk us through their incredible shared journey and industry insights as they prepare to celebrate their 50th wedding anniversary. https://www.linkedin.com/company/predictive-monitor-llc/ Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| Rural India to Silicon Valley: an entrepreneur's journey with Mohan Uttarwar, co-founder & CEO of 1Cell.AI | 27 Oct 2025 | 00:29:38 | |
Today we’re talking to Mohan Uttarwar, an accomplished entrepreneur and innovator with extensive expertise in life sciences and precision diagnostics, as he walks us through his fascinating journey from an Indian village without electricity to the bleeding edge of Silicon Valley tech innovation. Mohan's work focuses on addressing unmet needs in oncology and personalized medicine, and he’s particularly focused on the development of next-generation diagnostic tools, specifically in the areas of liquid biopsy and multi-omics. Based in Cupertino, California, Mohan is the co-founder and CEO of OneCell Diagnostics, now 1Cell.AI. 1Cell’s AI-powered cancer diagnostics promise 90% faster detection of cancers, and 80% more accurate therapy response plans. Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| Special episode! Digging into Qualio's 2025 quality trends report | 26 Mar 2025 | 00:15:53 | |
We made a bonus episode of From Lab To Launch to mark a special occasion: the launch of Qualio's fourth annual life science quality trends report in March 2025. Note: the audio in this episode has been made using artificial intelligence Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| Expanding Med Device Distribution Internationally and in China with Andy Levien CEO at ArcScan | 12 May 2021 | 00:21:05 | |
Andy Levien, President and CEO of ArcScan talks to Robert about expanding his medical device company internationally and into China. And because the system is not handheld, diagnostic measurements have never been this precise. ArcScan’s many innovations have led to a number of issued and pending ArcScan patents. Due to the success of accommodating intra-ocular lenses and the ever-growing refractive surgery market, intelligent imaging and precise measurements are more necessary than ever before.
Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| Empowering Women With Personal Fertility Knowledge with Dr. Amy Beckley of MFB Fertility | 27 Apr 2021 | 00:17:31 | |
Dr. Amy Beckley, founder and CEO of MFB Fertility and inventor of the Proov fertility test joins the show to talk about her journey as a scientist going through infertility herself to searching for answers and inventing a solution. With a PhD in Pharmacology and expertise in hormone signaling, she began tracking her own hormone levels at home. In doing so, she started to suspect that she had a problem with ovulation —which was causing her to lose pregnancy after pregnancy. Empowered by this knowledge, she went to her doctor and got a prescription for hormone supplements. With these supplements, she was able to conceive without the help of IVF, and maintain a healthy pregnancy. After her daughter was born, her mission was clear—to empower women with vital knowledge that could help in their ability to conceive. She founded MFB Fertility, Inc. and invented the Proov test in her own basement, which now allows women to confirm successful ovulation by tracking PdG in just five minutes, at home. Show notes:
Music by keldez Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| Defining Quality: The Role, Responsibilities, and Industry with Laura Araujo from 4G Clinical | 21 Apr 2021 | 00:20:27 | |
Today we're excited to have Laura Araujo, Vice President of Quality at 4G Clinical share her insight into quality management. 4G Clinical’s focus and mission is to bring crucial medicines to those who need them faster. 4G Clinical delivers modern, flexible and validated randomization and trial supply management solutions to Pharma and CROs faster than anyone else in the world. Laura has over 30 years of experience in Quality Assurance and Technology, holding various positions in Software Development, Quality Assurance, Software Auditing, and Technology Management. She has had positions in, or related to, the pharmaceutical industry for 25 years, including owning and running her own consulting firm for 10 years. During our conversation today, we talk about 4G Clinical and what they have accomplished, especially during the pandemic, Laura’s experience of working as a consultant, switching career paths and entering the Quality space, and much more! Show Notes: Music by keldez Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| Lessons from Bringing New Tech to Developing Countries and Pro Basketball with Assaf Barnea, CEO of Sanara Ventures | 14 Apr 2021 | 00:17:56 | |
Today we welcome Mr. Assaf Barnea to the show. He is a former pro basketball player in Europe and currently the CEO of Sanara Ventures, a healthcare innovation fund backed by Phillips and Teva Pharmaceuticals investing in digital health and medical device technologies. Sanara invests primarily in early stage digital health and bio convergence companies. He offers his insight and outlook on bio convergence in the future. Assaf also shares experiences as the co-founder of the World Bank’s International Finance Corporation’s Tech Emerge Initiative, which is a unique acceleration platform that connects healthcare startups from around the world with leading corporations and hospitals in emerging economies. He talks about the work done in India, Brazil, and now Africa. Truly inspiring and life-changing work. In his career, Mr. Barnea co-founded CardioSense, a medtech startup company, served as CEO of Kinrot Ventures spearheading its acquisition by Hutchison Water in 2012. He spearheaded business development at Mekorot, Israel’s national water company, where he oversaw the establishment of WaTech, the Entrepreneurship & Partnership Center for Water Technologies, where he received the Cleantech Group’s Innovation Hero Award. A unique highlight in Assaf’s story is basketball. At New Jersey’s Seton Hall University he and his team won the Big East championship against Georgetown in 1991 playing against Dikembe Mutombo and Alonzo Mourning. He played professionally in Europe for years and shares some parallels between athletic prowess and entrepreneurship. We’re excited to have him share his perspective and advice for entrepreneurs on today’s show. Music by keldez Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| 5 Innovative Med Device Startups to Watch | 31 Mar 2021 | 00:09:09 | |
It only takes one ground-breaking MedTech startup to change a product category forever. Back in 2006, serial entrepreneur Steve Kelly partnered with MIT researchers to take an anti-bleeding gel product to market. The biodegradable gel was a significantly better option for many hemostat applications, compared to alternatives like bandages, surgical clamps, tissue adhesives, vasoconstrictors, and cauterization. Today, topical hemostatic agents are considered the most efficient, effective, and safe option to stop bleeding in many patients and conditions. Winning medical device startups have a few factors in common, according to McKinsey research. First, they all have an idea that can provide consistently superior experiences to all users, including patients, caregivers, and clinicians. They will also “reimagine processes to dramatically reduce costs and accelerate decision making.” The most successful MedTech companies manage to get closer to the patient by providing an innovation that’s better, cheaper, safer, more convenient, or somehow just a better option. In order to get close to the patient, MedTech startups need to achieve velocity in the early stages to provide proof-of-concept, secure funding, and demonstrate clinical safety for regulatory approval. There’s no room for mistakes or delays in a hyper-competitive market space. A strong baseline of compliance is crucial from day one to ensure there are no barriers to obtaining FDA approval or a CE Mark. That's one of the reasons we exist. Qualio is quality management software for the life sciences ecosystem. If you can think of any other innovative companies that we should feature on from lab to launch, Let us know by filling out this form: Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| Curing Incurable Diseases with Jeff Galvin of American Gene Technologies | 25 Mar 2021 | 00:26:03 | |
What if incurable diseases like HIV, cancer, PKU, and epithelial solid tumors were completely curable? We're closer than you might think. Really close. In fact, Jeff Galvin and his team at American Gene Technologies™ (AGT) have been advancing the research and application of viral vectors for several years with some incredibly exciting breakthroughs on the horizon (hint: curing HIV could be just a few years away). In case you didn't know already, viral vectors is a relatively new technology where you can crack open any virus, scoop out the malevolent code and replace it with code to attack the root drivers of what are today incurable diseases. Essentially this creates a "stealth bomber" benevolent virus in your body. The future of this treatment could "send radiation and chemotherapy the way of bloodletting and leeches" as Jeff says in this podcast. Jeff has a contagious energy for gene technology and a grand vision of the future of curing the incurable. If you want to get a peak at how gene technology could quite literally change the world (and soon!) listen to what Jeff has to say. Enjoy! About Jeff Galvin Jeff Galvin is the CEO and Founder of American Gene Technologies™ (AGT). He earned his BA degree in Economics from Harvard in 1981 and has more than 30 years of business and entrepreneurial experience including founder or executive positions at a variety of Silicon Valley startups. Several of his companies were taken public and/or sold to public companies, including one in the medical-technology arena that was sold to Varian, the leading maker of linear accelerators used in cancer therapy. Following his startup experience, he retired to become an Angel Investor in real estate and high tech. He came out of retirement to found and fund AGT after meeting Roscoe Brady at NIH. Show notes:
Music by keldez Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| How to Get Non-Dilutive Funding via Federal Agencies with Ram May-Ron, Partner at FreeMind Group | 17 Mar 2021 | 00:20:31 | |
Over $50B (with a B!) is available each year to life science companies from federal agencies. The best part is, it's all non-dilutive funding. FreeMind started in 1999 and has grown into the largest consulting group of its kind. With experience in seeking funding from nearly all NIH Institutes, Department of Defense, NSF, FDA, BARDA, etc., as well as private foundations, they’ve helped clients garner over 1.5 billion dollars to date. Awards range from $150,000 to $150,000,000 per project. If funding is on your mind - you need to consider what Ram has to say here. Show notes: Music by keldez Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| Awakening Millions with Brain-Computer Interfaces with Andreas Forsland, CEO of Cognixion | 10 Mar 2021 | 00:20:59 | |
Imagine if Stephen Hawking couldn't communicate. The world's understanding of theoretical physics would be greatly limited. There are roughly half a billion people like Stephen Hawking who are just waiting for an awakening. They could communicate and contribute if they only had the technology to do so. Music by keldez Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| How to Maintain and Improve Your Quality Management While Working Remotely | 03 Mar 2021 | 00:22:24 | |
Today, we're introducing a new type of episode called Quality Quick Tips. Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| Quality Management Fundamentals in Aerospace, Life Sciences, and Antarctica with Gene Vought from Cirris Systems | 24 Feb 2021 | 00:19:54 | |
Cables are everywhere, quite literally. Quality management for a cable testing company can be challenging, especially with continuous audits from partners, but Gene Vought makes it look easy. Music by keldez Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| Mind the gap! Advancing transplantation with Tina Liedtky, President of the Transplant Diagnostics Division, Thermo Fisher Scientific | 12 Mar 2025 | 00:20:06 | |
As the organ transplant list continues to grow, experts in the transplant diagnostics industry are looking for ways to address the supply and demand challenges within the field. New tactics, like retransplantation and xenotransplantation, and new testing methods, such as HLA testing and transplant diagnostics, are being explored to boost transplant success rates and ensure more patients get the lifesaving transplants they need. As President of Thermo Fisher Scientific’s transplant diagnostics division, Tina Liedtky is at the cutting edge of meeting this challenge. She’s also passionate about addressing health equity issues, such as ingrained biases regarding gender and race, to help bridge the transplantation gap. Tina joined Meg for a fascinating discussion about the future of transplantation, closing 'the gap', and Thermo Fisher's recent award. Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| Improving Patient Safety at The Point of Care with Joan Melendez of Xcelrate UDI | 17 Feb 2021 | 00:23:27 | |
Did you know about $6 billion is spent each year in medical device recall management? Music by keldez Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| Funding and Scaling Your Med Device Startup with Jen Baird, CEO of Fifth Eye | 10 Feb 2021 | 00:26:42 | |
Getting funding and scaling a medical device business alone is challenging. But challenges don't deter entrepreneurs like Jen Baird. From being disregarded at first from VCs simply because she was a woman, to then selling her company for $205M, to today scaling a med device startup with a denovo FDA application, Jen has done it all! If that's not impressive enough, she takes time to write her insights as a startup CEO in her personal blog.
Jen's Photo credit Leisa Thompson Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| Reducing Patient and Nurse Injuries with Charleen Solomon from AriseQ2 | 02 Feb 2021 | 00:23:36 | |
Did you know nurses are required to turn and change bed-bound patients every two hours? The primary reason for this protocol is to help patients avoid pressure ulcers. At first glance, that seems like a straightforward and quick task. But it's actually quite a challenge, especially when nurses are short-handed. The traditional approach of turning patients is time consuming and prone to injuring nurses.
Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| Lessons from Building an Open Source Quality Community with Gill Berry | 27 Jan 2021 | 00:27:57 | |
Gillian Berry is a qualified clinical nurse specialist and founder of PerCen Technologies. She founded PerCen Technologies in response to challenges she felt were not addressed in Healthcare. It’s aim is to use scientific knowledge and the latest technologies to compliment clinical evidence based practice. PerCen Technologies is supported by the first national Health Innovation Hub of Ireland. We love seeing healthcare innovation coming out of Ireland, so we had to talk to Gill. ;) Gill shares her takeaways after co-founding one of the first open source efforts in response to the Covid19 pandemic, the Open Source ventilator project and the Open Source Volunteers Extended network. She managed over 1,000 STEM professional volunteers, academic institutions, SME’s and Multi-National’s and facilitated 30 projects with a transfer of knowledge and skills. It’s amazing what can be accomplished when we network, open source ideas, and collaborate together. Gillian’s story and lessons learned about the power of a network are certainly inspiring and applicable today. Music by keldez Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| How AI is Revolutionizing Healthcare Products and Access with Sam Dribin | 20 Jan 2021 | 00:21:46 | |
For the first time in healthcare, human ambition and technology are starting to intersect and AI is one of the main drivers. Listen in on this episode with Sam Dribin to learn about how AI is evolving to improve healthcare results. Music: Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| Unlock Funding with IP and Focusing Your Purpose. The inspiring story behind HAI Solutions with Nick Perrenoud. | 13 Jan 2021 | 00:24:51 | |
The story behind HAI Solutions is so inspiring and similar to many life science entrepreneurs who start their companies after personal (and occasionally tragic) experiences. Nick Perrenoud is one of those entrepreneurs. He's the co-founder of HAI Solutions and led the development and patent for a solution to protect patients from the accidental or negligent contamination of IV anesthesia medications. Nick learned the importance of protecting patients with sterile IVs, not only as a nurse anesthetist, but also when caring for his adopted son who required IVs for seven years and spent nearly three years in the hospital to, to central line infections. He shares many useful insights for any medical device entrepreneur such as how securing patents has helped with fundraising, focusing on your purpose, and being patient-driven. Enjoy!
Music: Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| Spearheading the Life Sciences Industry with Claire Bonaci from Microsoft | 06 Jan 2021 | 00:23:50 | |
Listen to this chat between Qualio CEO, Robert Fenton and Claire Bonaci from Microsoft about how the life science industry is evolving. We cover a wide of topics and trends based on her expertise and how she aspires to inspire young women interested in STEM and leadership roles. She brings with her an expertise in the clinical trial and pharmaceutical industry, having been a global study lead on oncology clinical trials at a large pharmaceutical company prior to joining Microsoft. She has deep understanding of the clinical trial value chain and the complex nuances that biotechnology and life science companies experience. She is passionate about the many services and innovations Microsoft has to offer to reduce time to market for new drugs and provide better outcomes to patients. Claire is also the producer and host of the Confessions of Health Geeks podcast, an industry focused podcast on the biggest trends and pain points in health and life sciences. Claire also has a passion for inspiring young women to be interested in STEM and leadership roles in STEM related fields.
Music by keldez Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| Global Opportunities from Starting a Med Device Company in a Pandemic with Meow-Ludo. | 30 Dec 2020 | 00:21:38 | |
Our guest today is Meow-Ludo. He’s an emerging technology evangelist and Chief Scientific Officer at Moth Diagnostics, a company formed in response to the covid pandemic. Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| Giving back to those on the Frontlines of Healthcare with Robert Fenton and Mark Ryle | 22 Dec 2020 | 00:43:29 | |
2020 has been an unprecedented year. In times like these, mission-driven companies should challenge themselves to stay focused on their immediate goals while not losing sight of their bigger vision. In an effort to reinforce our mission and demonstrate our values, Qualio is committing to what we call 1% For All Life. Starting this year, Qualio will donate 1% of our annual revenue to improving healthcare access for vulnerable populations. Qualio's mission is to enable organizations to launch and scale life-saving products. While this supports our core belief that everyone deserves to live a long, happy, and healthy life, we are now expanding our mission by supporting organizations that ensure underserved communities receive the healthcare they need. Increasing the quantity and quality of treatment options does little to help those who cannot easily access the existing healthcare system. I saw this first hand while working as a pharmacist in large urban centers, rural communities, and drug addiction services in Ireland's largest prison. It became clear to me that the ability to access quality healthcare has an enormous impact on people's lives, and that we all have an opportunity to make a difference here. After months of living through a global pandemic, we feel privileged to be able to give something to those that need better healthcare access. Here is where our donations will go in 2020:
To all our wonderful teammates, customers, and partners - thank you from the bottom of our heart for making all of this possible.
Music by keldez Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| From Hippie to Med School to Entrepreneur with Dr. Hana Solomon, MD | 16 Dec 2020 | 00:19:34 | |
If you have a nose, you should check out this episode.
Music by keldez Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| The predictive power of biomarkers with Mark Roskey, CSO of Quanterix | 11 Feb 2025 | 00:16:55 | |
As more preventative approaches to health are set to take center stage, some diseases can’t be prevented but can be managed more proactively. Blood-based biomarkers, such as p-tau217, hold great promise for earlier, more proactive detection and monitoring of diseases such as Alzheimer’s, and it’s here that Quanterix plays a critical role. Their Simoa digital health platform serves as the backbone for the majority of p-tau217 tests on the market today, reducing reliance on costly PET and CSF testing and streamlining the diagnostic journey for Alzheimer’s disease. Mark has been a leader in the biotech space for over 2 decades, with a string of leadership roles before he joined Quanterix in 2014 and became their CSO in 2022. Mark joined Meg on From Lab To Launch to discuss the exciting predictive power of biomarker technology, and what the future holds for spotting and treating diseases early. Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| 4x cancer survivor to CEO/Founder. The power of patient-led solutions with Cinde Dolphin. | 09 Dec 2020 | 00:21:23 | |
What if the next time you went to the receive healthcare at a clinic or hospital, you came out with an idea to improve the patient's experience? That's what Cinde Dolphin did.
Music by keldez Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| Insights from Biotech Pioneer and Investor Ron Shigeta | 03 Dec 2020 | 00:22:49 | |
Ron Shigeta is a serial entrepreneur & startup biotech pioneer. He’s also been a serial founder having run startups in AI drug tox detection & synthetic biology. Ron holds a PhD in Chemistry from Princeton University, where he spent his academic research career focusing on secondary metabolic biosynthesis, diabetes, genomics, genetics, structural biology and systems biology. As an entrepreneur, investor, scientist, and mentor Ron shares some great insights to anyone who wants to contribute to life sciences.
Links:
Music by keldez Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| Trailer | 24 Nov 2020 | 00:00:45 | |
Welcome to the From Lab to Launch podcast by Qualio. Discover inspiring stories from those on the front lines of life sciences. You’ll hear founders share their insights from launching and scaling their business, investors giving their outlook on funding, industry experts unfolding their latest insights and research, and quality professionals offering advice to navigate the regulatory maze and avoid audit pitfalls. Episodes are about 30 minutes and published each week on all major podcast players. Tune in and leave inspired to bring your life saving products to the world.
Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| Advancing Pathology using AI with Joseph Mossel Co-founder & CEO of Ibex | 19 Nov 2024 | 00:28:37 | |
In this episode of From Lab to Launch by Qualio we interview Joseph Mossel, CEO and co-founder of Ibex Medical Analytics. Joseph shares his journey from computer science to leading a transformative AI-driven company in pathology. Founded in 2016, Ibex aims to provide accurate, timely, and personalized cancer diagnoses using AI technology. Joseph discusses the challenges and insights from deploying AI in clinical settings, the importance of partnerships, and the company's vision for the next few years. Tune in to learn how Ibex's innovations are reshaping cancer diagnostics and making a significant impact on patient outcomes. https://www.linkedin.com/in/yossimossel/
Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| The future of clinical trials with Sarah Englert, Senior Director of Innovation & Program Management at Thermo Fisher Scientific | 21 Oct 2024 | 00:25:45 | |
Earlier this year, Thermo Fisher Scientific opened its first clinical trial Innovation Lab in Center Valley, Pa., designed to foster a culture of collaboration by providing a dedicated space for industry partners to come together, share ideas and co-create solutions for the industry’s biggest challenges. The global clinical trial market was valued at over $80 billion in 2023, and that’s projected to grow by 6.5% every year until 2030. But alleviating innovation silos is the only way to move the clinical trial industry forward and tackle its current challenges. Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| The future of protein manufacturing with Kerry Love, co-founder of Sunflower Therapeutics | 07 Oct 2024 | 00:19:55 | |
Today we welcome Kerry Love, the co-founder of Massachusetts-based (and wonderfully named) Sunflower Therapeutics. Established in 2018, Sunflower is dedicated to advancing biologic medicines and enhancing global vaccine accessibility through cutting-edge protein manufacturing technologies. As a women-owned organization, Sunflower has a stellar team of scientists and engineers renowned for their expertise in perfusion fermentation, purification process development, biopharmaceutical manufacturing, and quality management. Their mission-driven approach revolves around simplifying bioproduction complexities with their modular, automated, and fully integrated platform. This transformative technology empowers innovators to swiftly manufacture critical biologic products precisely where they're needed most. Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| Revolutionizing kidney health with Salvatore Viscomi, CEO of Carna Health | 24 Sep 2024 | 00:25:38 | |
Carna Health is focused on applying technology to revolutionize kidney care by unlocking the early detection and management of chronic kidney disease (CKD). They provide clinical-grade software as medical devices that deliver instant health metrics, such as creatinine, eGFR, and uACR levels, from small patient samples. Their platform integrates with existing healthcare systems and electronic healthcare records, promoting proactive and patient-centric care underpinned by accurate, real-time patient data. CEO and co-founder Salvatore Viscomi, MD, joined Meg to talk about the Carna Health mission, where current kidney care is going wrong, and what the future holds for kidney patients. https://www.linkedin.com/in/salvatore-viscomi/ Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| Pioneering in Genetic Research with Dr. Jonathan Hill of Wasatch Biolabs | 10 Sep 2024 | 00:29:47 | |
Dr. Jonathan Hill, VP of Science and Technology and co-founder of Wasatch Biolabs joins the podcast today to talk about the future of genetic testing technology. https://www.linkedin.com/in/jonathon-t-hill/ Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| Sepsis Detection Made Rapid and Accurate with Dr. Rolland Carlson CEO of Immunexpress | 29 Aug 2024 | 00:28:34 | |
Join us with guest Dr. Rolland Carlson, CEO of Immunexpress to talk about the transformative work happening in sepsis diagnosis. https://www.linkedin.com/in/rollie-carlson-ph-d-059074a/ Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| Continuing Early Cancer Detection with David Suhy Co-founder of Earli | 12 Aug 2024 | 00:29:34 | |
In this episode we bring David Suhy, co-founder and Chief Scientific Officer at Earli back to the podcast. David shares the heartfelt founding story of Earli, the company's mission to make cancer a benign experience by catching it early, and their unique approach utilizing synthetic promoters for early cancer detection and treatment. https://www.linkedin.com/in/davidsuhy/ Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| The magic formula of population-based predictive analytics with Dr. Terrance Govender, VP of Medical Affairs at ClinIntell | 13 Oct 2025 | 00:18:16 | |
Today on From Lab To Launch, we’re excited to welcome Dr. Terrance Govender, the VP of Medical Affairs at ClinIntell. ClinIntell, based in Tampa, Florida, supports healthcare executives and leaders in accurately capturing the true severity of their inpatient population using population-based predictive analytics. The results for their customers? More accurate, trustworthy performance data and clinical condition reporting, that can be easily shared and used to drive continuous improvement activities. Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| Innovative Approaches to Medication-Assisted Addiction Treatment with Dr. Joshua Lee | 31 Jul 2024 | 00:32:29 | |
This episode we're joined by Dr. Joshua Lee, a clinician, researcher, and professor specializing in medication-assisted treatment (MAT) for alcohol and opioid use disorders. Dr. Lee discusses his extensive research on medications such as naltrexone and buprenorphine, their significance in treating substance use disorders, and the transformative potential of telemedicine platforms like Oar Health. He highlights the underutilization of effective medications in primary care, the barriers to accessibility, and the enduring stigma associated with addiction. The conversation also touches on emerging trends and the future of addiction treatment. Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| Combatting the Opioid Crisis with Technology with Justin Zenanko CEO of SynerFuse | 16 Jul 2024 | 00:21:10 | |
In this episode we're joined by Justin Zenanko, CEO and co-founder of SynerFuse to discuss groundbreaking technique combining spinal fusion and direct nerve stimulation to treat chronic low back pain, aiming to eliminate the need for postoperative opioids. Justin delves into the inspiration behind the technology, its clinical results, and the company's approach to quality and regulatory management. He also provides insights on raising funds in a competitive market and the potential future applications of SynerFuse's technology. Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| Epilepsy Breakthroughs and Beyond with Jason Tardio and Toshiya Nishi from Ovid Therapeutics | 28 Jun 2024 | 00:23:58 | |
**UPDATE** Since this episode was recorded, Takeda announced the results of the phase 3 soticlestat trials, which did not meet their primary endpoints. Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| Pioneering Viral Diagnostics with Dr. Nigel McCracken COO of Virax Biolabs | 18 Jun 2024 | 00:26:07 | |
Join us as we discuss viral diagnostics and pharmacology with Dr. Nigel McCracken, Chief Operating Officer of Virax Biolabs. Dr. McCracken shares his expertise in drug development, focusing on oncology and infectious diseases, and discusses the company's pioneering work in detecting immune responses and diagnosing viral diseases. The conversation covers the impact of technology advancements in the past decade, the introduction of the Immune Select Profile in the Virax Immune T Cell Diagnostic Platform, and the evolving landscape of viral diagnostics post-COVID-19. Dr. McCracken also shares insights on maintaining high-quality standards in R&D and offers advice for aspiring professionals in the fields of drug development and diagnostics. Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| Lowering Anxiety using Smart Weight Technology with Marna Pacheco Founder of CapeAble Weighted Products | 30 May 2024 | 00:22:37 | |
Join us in this inspiring episode of From Lab to Launch as we sit down with Marna Pacheco, the innovative founder of CapeAble Weighted Products. Marna turned a personal challenge into a pioneering enterprise that integrates fashion with function, providing therapeutic weighted products to those in need, from individuals with autism to medical patients across various settings.
Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| Transforming Neuropsychiatric Therapeutics with Dr. Sam Clark, CEO of Terran Biosciences | 15 May 2024 | 00:23:29 | |
This episode of the From Lab to Launch podcast, brought to you by Qualio, features Dr. Sam Clark, CEO of Terran Biosciences. With a background in neurosciences from MIT and an MD and PhD from Columbia University, Dr. Clark shares his journey from academia to leading a pioneering company in neuropsychiatric therapeutics. He discusses the challenges and innovations in the development and supply of GMP psychedelic compounds, highlighting how these substances are making significant strides toward transforming mental health treatment. Dr. Sam Clark's LinkedIn: https://www.linkedin.com/in/sam-clark-md-phd-133139199/
Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| Treating Neurodegenerative Diseases with Rob Etherington, CEO of Clene Nanomedicine | 24 Apr 2024 | 00:26:09 | |
Listen in on our conversation with Rob Etherington, CEO of Clene Nanomedicine, a company pioneering nanotherapeutics for neurodegenerative diseases like ALS, multiple sclerosis, and Parkinson's. Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| Saving Lives by Cancer Prediction and Detection with Dan Lunz, CEO of Previse | 27 Mar 2024 | 00:25:17 | |
Today we interview with Dan Lunz, co-founder and CEO of Previse, an innovative medical solutions company specializing in cancer prevention and early detection. Lunz talks about his journey from being a Marine to leading a pioneering medical company. He discusses the scientific technology behind Previse, which started out as research for predicting esophageal cancer in patients with Barrett's esophagus. Lunz also shares about the company's current fundraising activities, commercialization plans, compliance with regulatory standards, and long-term goals for cancer detection. He hints at exciting future announcements about Previse's new developments, tests, and pipeline technologies. https://www.linkedin.com/in/danlunz/
Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| The Power of Effective Writing in the Life Sciences Industry with Pam Hurley, Founder of Hurley Write | 13 Mar 2024 | 00:22:59 | |
In this episode we welcome Pam Hurley, the founder and president of Hurley Write Inc., who specializes in professional writing and communication training. Pam discusses how proper writing can lead to more effective professional communication in life sciences, and how precision and confidence in writing can help professionals achieve their goals.
Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| Advancing Cancer Diagnostics with Mark McDonough, CEO of Chromacode | 26 Feb 2024 | 00:20:35 | |
In this episode we interview Mark McDonough, the CEO of ChromaCode. The episode explores McDonough's journey to ChromaCode, from his early career as a naval officer to his roles at various medical and diagnostic companies. Under McDonough's leadership, ChromaCode has excelled in creating a high-definition PCR platform which enables fast, accurate, and affordable cancer diagnosis. The platform is particularly beneficial as it requires less patient tissue, provides rapid results, and has a lower cost than traditional diagnostic methods. McDonough also discusses the importance of partnerships in their go-to-market strategy and shared his insights on hiring and team development in today's competitive market. Looking ahead, ChromaCode expects to become a leader in developing innovative products for disease diagnosis, with a focus on patient-centered outcomes. https://www.linkedin.com/in/mark-mcdonough-b1055216/
Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| The proof is in the protein with Dr. Jonathan Usuka, CEO of Sapient | 29 Sep 2025 | 00:16:44 | |
If you’ve been following From Lab to Launch for a while, you may remember a previous conversation with Sapient’s Chief Scientific Officer, Dr. Mo Jain, a couple years back. We’re thrilled to build on that conversation with Dr. Jonathan Usuka, the CEO of Sapient. Sapient is one of the largest capacity biomarker discovery labs in the world, and their mission is to accelerate drug development and improve patient outcomes through biomarker-guided therapeutics. By combining high-resolution biomolecular data with advanced computational approaches, Sapient is helping sponsors and researchers unlock new therapeutic targets and navigate complex biology at unprecedented speed and scale. With more than 25 years of experience at the intersection of business, science, and technology, Jonathan has led innovation strategies across drug development, diagnostics, and AI-driven discovery. From streamlining therapeutic pipelines to pushing the boundaries of integrated diagnostics, his work is helping reshape how biopharma organizations bring life-changing therapies to patients. Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| Unlocking Longevity using ESS60 with Chris Burres Co-Founder of MyVitalC | 23 Jan 2024 | 00:27:15 | |
Join us as we dive into the world of groundbreaking scientific discovery with Chris Burres, a renowned Chief Scientist. In this episode, Chris unveils the mysteries of a unique, soccer ball-shaped molecule that could be the key to unlocking secrets of health and longevity. Discover how this extraordinary molecule, small enough to hold any atom from the periodic chart, might revolutionize our understanding of wellness and aging. Chris shares insights into the foundational principles that drive this innovative research and the potential life-changing benefits it holds. Furthermore, hear firsthand the compelling success stories and testimonials from users of "MyVitalC." These narratives not only shed light on the practical implications of Chris's work but also illustrate the profound impact this discovery could have on our daily lives. Whether you're a science enthusiast, a health and wellness aficionado, or simply curious about the latest in scientific breakthroughs, this episode promises to offer a fascinating blend of scientific exploration and real-world applications. Tune in to get a glimpse into the future of health science with Chris Burres guiding the way. https://www.myvitalc.com/ Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| Innovative Lab Spaces and Cleanrooms on Demand with Azzur Group's Ravi Samavedam | 09 Jan 2024 | 00:18:05 | |
In this episode of "From Lab to Launch" by Qualio, Meg welcomes Ravi Samavedam, the Chief Innovation Officer of Azzur Group. With over two decades of experience as a seasoned biochemical engineer, Ravi is a driving force behind Azzur's groundbreaking approach to lab spaces and cleanrooms. Discussion Highlights: The conversation explores how Azzur ensures GMP compliance in multiproduct facilities, emphasizing quality systems and strict agreements. Ravi elaborates on Azzur's one-stop-shop approach, providing a range of services under one roof, from testing labs to consulting. The discussion touches on the lab space shortage, both pre- and post-COVID, and the potential implications for the industry. Ravi shares insights into emerging trends, expressing particular excitement for the potential decentralization of cell therapy manufacturing near hospitals. The episode concludes on a lighter note as Ravi reveals his personal interest in geography. Connect and Learn More: This episode provides a comprehensive understanding of Azzur Group's transformative contributions to the biotech and pharma sectors, offering a glimpse into the future of flexible and efficient lab spaces. Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||
| Transforming Healthcare Access: Navigating Challenges and Unlocking Data with Particle Health's Troy Bannister | 07 Dec 2023 | 00:23:21 | |
In this episode, Meg is joined by Troy Bannister, the co-founder and chief strategy officer at Particle Health. Particle Health is a company revolutionizing the accessibility, sharing, and utilization of healthcare data to simplify navigation for patients and healthcare providers. Troy shares his inspiration behind starting Particle Health and dives into the challenges and strategies the company employed to navigate regulatory compliance and foster successful partnerships in the highly regulated healthcare industry. The conversation delves into the importance of caring passionately about the mission, overcoming setbacks, and the role of partnerships in achieving Particle Health's mission. Troy provides insights into the evolving landscape of healthcare data sharing, emphasizing the potential for emerging trends and technologies to democratize healthcare data, leading to increased innovation and benefits for individuals. https://www.linkedin.com/in/troy-bannister-259a3235/ Qualio website: Previous episodes: Apply to be on the show: Music by keldez | |||